Upsher-Smith Laboratories

In April 2024, Bora Pharmaceuticals acquired Upsher-Smith, leading to our merger with TWi Pharmaceuticals in July 2024. This strategic move allowed us to incorporate TWi’s products into our extensive portfolio. By uniting our diverse product range with TWi’s specialized R&D capabilities, we are set to fuel our pipeline and elevate product development to new heights.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore Pharmaceuticals profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Upsher-Smith Laboratories.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

In April 2024, Bora Pharmaceuticals acquired Upsher-Smith, leading to our merger with TWi Pharmaceuticals in July 2024. This strategic move allowed us to incorporate TWi’s products into our extensive portfolio. By uniting our diverse product range with TWi’s specialized R&D capabilities, we are set to fuel our pipeline and elevate product development to new heights.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.